Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Yu, Hongping ^a,b   Liu, Zhensheng ^b   Huang, Yu Jing ^b   Yin, Ming ^b   Wang, Li E ^b   Wei, Qingyi ^b  

^a Department of Epidemiology and Biostatistics   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EUROPEAN AMERICAN; EXCISION REPAIR CROSS COMPLEMENTATION GROUP 4 GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; VIRUS CELL TRANSFORMATION; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

HUMAN HERPESVIRUS 4;

EID: 84864416491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041853     Document Type: Article

References (50)

1. Wood RD, Mitchell M, Sgouros J, Lindahl T,((2001)) Human DNA repair genes. Science 291:: 1284--1289.
2. Garfinkel DJ, Bailis AM,((2002)) Nucleotide Excision Repair, Genome Stability, and Human Disease: New Insight from Model Systems. J Biomed Biotechnol 2:: 55--60.
3. Wood RD,((1997)) Nucleotide excision repair in mammalian cells. J Biol Chem 272:: 23465--23468.
4. Mohrenweiser HW, Wilson DM 3rd, Jones IM,((2003)) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 526:: 93--125.
5. Wei Q, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, et al.((2003)) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95:: 308--315.
6. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, et al. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res 16:: 764--774.
7. Wei Q, Cheng L, Hong WK, Spitz MR,((1996)) Reduced DNA repair capacity in lung cancer patients. Cancer Res 56:: 4103--4107.
8. Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, et al.((2004)) Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25:: 1695--1700.
9. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, et al.((2007)) Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res 13:: 6532--6539.
10. Fan F, Liu C, Tavare S, Arnheim N,((1999)) Polymorphisms in the human DNA repair gene XPF. Mutat Res 406:: 115--120.
11. Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, et al.((2004)) The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol 24:: 5776--5787.
12. Ahmad A, Robinson AR, Duensing A, van Drunen E, Beverloo HB, et al.((2008)) ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol Cell Biol 28:: 5082--5092.
13. Tian M, Shinkura R, Shinkura N, Alt FW,((2004)) Growth retardation, early death, and DNA repair defects in mice deficient for the nucleotide excision repair enzyme XPF. Mol Cell Biol 24:: 1200--1205.
14. Brookman KW, Lamerdin JE, Thelen MP, Hwang M, Reardon JT, et al.((1996)) ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs. Mol Cell Biol 16:: 6553--6562.
15. Lehmann AR,((2003)) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85:: 1101--1111.
16. Kraemer KH, Lee MM, Andrews AD, Lambert WC,((1994)) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130:: 1018--1021.
17. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, et al.((2011)) Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 48:: 168--176.
18. van Steeg H, Kraemer KH,((1999)) Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 5:: 86--94.
19. Hoy CA, Thompson LH, Mooney CL, Salazar EP,((1985)) Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res 45:: 1737--1743.
20. Andersson BS, Sadeghi T, Siciliano MJ, Legerski R, Murray D,((1996)) Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol 38:: 406--416.
21. Koberle B, Ditz C, Kausch I, Wollenberg B, Ferris RL, et al.((2010)) Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo. Int J Oncol 36:: 1277--1284.
22. Liu C, Zhou S, Begum S, Sidransky D, Westra WH, et al.((2007)) Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. Lung Cancer 55:: 303--311.
23. Chang LC, Sheu HM, Huang YS, Kuo KW,((2000)) Quantitative determination of the expression of xeroderma pigmentosum F gene in human nonmelanoma skin cancers. Biochem Biophys Res Commun 273:: 454--458.
24. Langer R, Specht K, Becker K, Ewald P, Sarbia M, et al.((2004)) [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis]. Verh Dtsch Ges Pathol 88:: 207--213.
25. Wei Q, Wang LE, Sturgis EM, Mao L,((2005)) Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 14:: 1961--1966.
26. Vaezi A, Wang X, Buch S, Gooding W, Wang L, et al.((2011)) XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res 17:: 5513--5522.
27. Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, et al.((2003)) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:: 1200--1204.
28. Milne RL, Ribas G, Gonzalez-Neira A, Fagerholm R, Salas A, et al.((2006)) ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res 66:: 9420--9427.
29. Shao M, Ma H, Wang Y, Xu L, Yuan J, et al.((2008)) Polymorphisms in excision repair cross-complementing group 4 (ERCC4) and susceptibility to primary lung cancer in a Chinese Han population. Lung Cancer 60:: 332--339.
30. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, et al.((2000)) A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60:: 5612--5616.
31. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, et al.((2008)) Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 68:: 4928--4935.
32. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, et al.((2009)) Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125:: 1431--1439.
33. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, et al.((2006)) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15:: 536--542.
34. Niu J, Huang YJ, Wang LE, Sturgis EM, Wei Q,((2009)) Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. Carcinogenesis 30:: 2053--2058.
35. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, et al.((2010)) Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res 16:: 764--774.
36. Holm K, Melum E, Franke A, Karlsen TH,((2010)) SNPexp- A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11:: 600.
37. Project TIH((2003)) The International HapMap Project. Nature 426:: 789--796.
38. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al.((2007)) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:: 848--853.
39. McKay JD, Truong T, Gaborieau V, Chabrier A, Chuang SC, et al.((2011)) A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet 7:: e1001333.
40. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, et al.((2006)) Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 35:: 11--18.
41. Krupa R, Kasznicki J, Gajecka M, Rydzanicz M, Kiwerska K, et al.((2010)) Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population. Exp Oncol 33:: 55--56.
42. Knight JC,((2005)) Regulatory polymorphisms underlying complex disease traits. J Mol Med (Berl) 83:: 97--109.
43. Liu Z, Wei S, Ma H, Zhao M, Myers JN, et al.((2011)) A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 32:: 1668--1674.
44. Mohrenweiser H,((2007)) Survey of polymorphic sequence variation in the immediate 5′ region of human DNA repair genes. Mutat Res 616:: 221--226.
45. Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, et al.((2007)) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res 35:: 4535--4541.
46. Blitzblau RC, Weidhaas JB,((2010)) MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk. Mol Diagn Ther 14:: 335--342.
47. Pelletier C, Weidhaas JB,((2010)) MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert Rev Mol Diagn 10:: 817--829.
48. Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q,((2002)) Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94:: 393--397.
49. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, et al.((2006)) A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444:: 1038--1043.
50. Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei YF, et al.((1996)) Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 86:: 811--822.